| Primary |
| Depression |
26.6% |
| Major Depression |
13.8% |
| Hypertension |
10.3% |
| Diabetic Neuropathy |
8.3% |
| Diabetes Mellitus |
4.1% |
| Insomnia |
4.0% |
| Anxiety |
3.7% |
| Pain |
3.3% |
| Fibromyalgia |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Constipation |
3.0% |
| Migraine |
2.6% |
| Asthma |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Neuralgia |
2.1% |
| Parkinson's Disease |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Angina Pectoris |
1.4% |
| Back Pain |
1.4% |
|
| Death |
10.8% |
| Vomiting |
10.8% |
| Suicidal Ideation |
9.4% |
| Drug Toxicity |
8.5% |
| Suicide Attempt |
6.1% |
| Alanine Aminotransferase Increased |
5.2% |
| Syncope |
5.2% |
| Urinary Retention |
5.2% |
| Blood Bilirubin Increased |
4.2% |
| Loss Of Consciousness |
3.8% |
| Liver Function Test Abnormal |
3.3% |
| Liver Injury |
3.3% |
| Nausea |
3.3% |
| Psychotic Disorder |
3.3% |
| Restlessness |
3.3% |
| Cardiac Failure |
2.8% |
| Gamma-glutamyltransferase Increased |
2.8% |
| Jaundice |
2.8% |
| Rash |
2.8% |
| Rash Pruritic |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
27.3% |
| Drug Use For Unknown Indication |
20.7% |
| Depression |
9.8% |
| Major Depression |
5.5% |
| Diabetic Neuropathy |
5.0% |
| Hypertension |
4.4% |
| Insomnia |
3.3% |
| Type 2 Diabetes Mellitus |
2.8% |
| Suicide Attempt |
2.8% |
| Diabetes Mellitus |
2.6% |
| Pain |
2.5% |
| Constipation |
1.9% |
| Fibromyalgia |
1.8% |
| Schizoaffective Disorder |
1.6% |
| Anxiety |
1.5% |
| Diabetes Mellitus Non-insulin-dependent |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Metabolic Syndrome |
1.4% |
| Angina Pectoris |
1.1% |
| Bipolar Disorder |
1.1% |
|
| Completed Suicide |
18.5% |
| Respiratory Arrest |
8.5% |
| Death |
7.4% |
| Suicidal Ideation |
7.1% |
| Metabolic Syndrome |
6.0% |
| Serotonin Syndrome |
5.7% |
| Unresponsive To Stimuli |
4.3% |
| Toxicity To Various Agents |
4.0% |
| Overdose |
3.7% |
| Tumour Embolism |
3.7% |
| Cardio-respiratory Arrest |
3.4% |
| Hypokinesia |
3.4% |
| Suicide Attempt |
3.4% |
| Drug Toxicity |
3.1% |
| Poisoning |
3.1% |
| Vomiting |
3.1% |
| Weight Increased |
3.1% |
| Loss Of Consciousness |
2.8% |
| Mental Status Changes |
2.8% |
| Nausea |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
38.7% |
| Depression |
9.6% |
| Product Used For Unknown Indication |
8.2% |
| Rheumatoid Arthritis |
7.5% |
| Pain |
7.1% |
| Hypertension |
4.4% |
| Anxiety |
3.2% |
| Crohn's Disease |
2.9% |
| Insomnia |
2.4% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Psoriatic Arthropathy |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Fibromyalgia |
1.5% |
| Vitamin Supplementation |
1.4% |
| Intervertebral Disc Degeneration |
1.3% |
| Arthritis |
1.3% |
| Diabetes Mellitus |
1.3% |
| Narcolepsy |
1.2% |
| Prophylaxis |
1.2% |
| Diffuse Large B-cell Lymphoma |
1.2% |
|
| Weight Increased |
15.4% |
| Vomiting |
9.8% |
| Drug Ineffective |
7.9% |
| Pain |
5.9% |
| Injection Site Pain |
5.2% |
| Tremor |
5.2% |
| Incorrect Dose Administered |
4.9% |
| Suicide Attempt |
4.9% |
| Accidental Exposure |
4.3% |
| Flushing |
4.3% |
| Somnolence |
3.9% |
| Urticaria |
3.9% |
| Oedema Peripheral |
3.6% |
| Weight Decreased |
3.6% |
| Nausea |
3.3% |
| Pruritus |
3.0% |
| Wrong Technique In Drug Usage Process |
3.0% |
| Joint Swelling |
2.6% |
| Pain In Extremity |
2.6% |
| Septic Shock |
2.6% |
|
| Interacting |
| Depression |
22.1% |
| Parkinson's Disease |
12.8% |
| Pain |
10.6% |
| Product Used For Unknown Indication |
6.8% |
| Anxiety |
6.0% |
| Dementia |
6.0% |
| Post Herpetic Neuralgia |
5.5% |
| Ill-defined Disorder |
4.7% |
| Atrial Fibrillation |
4.3% |
| Crying |
4.3% |
| Cardiac Failure |
2.6% |
| Hypertension |
2.6% |
| Induction Of Anaesthesia |
2.6% |
| Drug Use For Unknown Indication |
1.7% |
| Hiv Infection |
1.7% |
| Histrionic Personality Disorder |
1.3% |
| Infection |
1.3% |
| Maintenance Of Anaesthesia |
1.3% |
| Panic Disorder |
1.3% |
| Anaesthesia |
0.9% |
|
| Drug Interaction |
15.6% |
| Serotonin Syndrome |
13.3% |
| Blood Pressure Increased |
11.1% |
| Dysstasia |
11.1% |
| Loss Of Consciousness |
6.7% |
| Delirium |
4.4% |
| Hyperhidrosis |
4.4% |
| Myoclonus |
4.4% |
| Pain In Extremity |
4.4% |
| Renal Failure Acute |
4.4% |
| Vision Blurred |
4.4% |
| Discomfort |
2.2% |
| Drug Effect Decreased |
2.2% |
| Pyrexia |
2.2% |
| Therapeutic Response Decreased |
2.2% |
| Tremor |
2.2% |
| Vomiting |
2.2% |
| Weight Decreased |
2.2% |
|
